
Luprotas 22.5mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Leuprolide (22.5mg)
Overview Luprotas 22.5mg Injection
Goserelin acetate 22.5mg injection treats prostate cancer, endometriosis (excessive uterine lining growth causing pain, heavy/irregular bleeding), uterine fibroids, and central precocious puberty (early onset puberty). Administered subcutaneously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; improper use can lead to severe adverse reactions. Therapeutic effects may take weeks or months; discontinue only upon medical advice. Common side effects include reduced libido, sweating, tiredness, muscle weakness, and hot flushes. Prolonged use can weaken bones; calcium and vitamin D supplementation is recommended. Amenorrhea (cessation of menstruation) for 7-12 weeks is expected; persistent bleeding warrants medical attention. Disclose alcohol consumption, smoking history, and osteoporosis before starting treatment. Inform your healthcare provider of all other medications, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Uses of Luprotas 22.5mg Injection
Managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
Major Benefits of Luprotas 22.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Luprotas 22.5mg Injection:
- Decreased libido
- Testicular atrophy
- Increased sweating
- Fatigue
- Muscle weakness
- Erectile dysfunction
- Hot flashes
How to use Luprotas 22.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Luprotas 22.5mg Injection works:
Luprotas 22.5mg Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves suppressing testosterone levels in males. In females, it achieves this by halting ovarian hormone synthesis, thus reducing estrogen and consequently menstrual flow.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while using Luprotas 22.5mg Injection. Physician consultation is recommended.
PregnancyUNSAFE
Administration of Luprotas 22.5mg Injection is contraindicated during pregnancy. Pregnant individuals should consult their physician, as research in both animal models and pregnant women has revealed substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Luprotas 22.5mg Injection with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administration of Luprotas 22.5mg Injection may induce adverse reactions impacting driving capabilities. Refrain from driving or operating equipment if drowsiness, dizziness, or visual impairment occurs during treatment with Luprotas 22.5mg Injection.
KidneyCONSULT YOUR DOCTOR
Data on the application of Luprotas 22.5mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of 22.5mg Luprotas injections to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Luprotas 22.5mg Injection :
Should you forget a scheduled injection of Luprotas 22.5mg, seek advice from your physician.
Facts to Know About Luprotas 22.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | GnRH Agonist |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
